Established in 1997, Valenta Pharm is a Russian innovative pharmaceutical company involved in development, production, and market launch of high-quality prescription and OTC medicines
Over the last 20 years, Valenta Pharm has successfully developed and launched a number of medicinal products for such therapeutic areas as immunology, virology and antibacterial therapy, psychoneurology, gastroenterology, urology, etc.
A balanced company portfolio comprises more than 90 medicines represented by both innovative pharma products and branded generics. The range of medicinal products includes such well-known brands as Ingavirin®, Grammidin®, Trimedat®, Teraligen®, Phenazepam®, Pantocalcin®, Aminazine®
More than 50% of medicines produced by Valenta Pharm are on the List of Vital and Essential Drugs
Valenta Pharm invests heavily in scientific research and portfolio development, as well as medical projects and health-related innovations
The Company currently produces over 100 million finished pharmaceutical products per annum within the major therapeutic categories of social importance
Valenta Pharm is a continuously developing company taking the lead among Russian pharmaceutical companies.
Business geography of Valenta Pharm covers 56 regions of Russia, as well as Belarus, Kyrgyzstan, Azerbaijan, Armenia, and Uzbekistan. Its subsidiary – Valenta Asia TOO – operates in Kazakhstan